Innovent Biologics

Innovent Biologics

Innovent Biologics

Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies.
Founded
2011
Raised
$831M
Follow us
Alexa global traffic share
Latest funding Show all
$421,000,000
IPO - 2018
Team Size
200+
Employees
Location
Headquarters
$421,000,000 IPO
AVCJ

Innovent Biologics gains on debut after $421m IPO

PE HUB

China's Innovent prices HK IPO near top end, raises $421 million, say sources: Reuters

PE HUB

China's Innovent Biologics looks to raise up to $422 million in HK IPO, say sources: Reuters

$150,000,000 Venture capital (Series E)
PE HUB , ChinaMoneyNetwork , AVCJ

CGPM leads $150 mln Series E for Innovent Biologics

Funding Technology
FinSMEs

Innovent Biologics Completes US$150M Series E Financing

Funding